1. Home
  2. IMMP vs SEG Comparison

IMMP vs SEG Comparison

Compare IMMP & SEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • SEG
  • Stock Information
  • Founded
  • IMMP 1987
  • SEG 2024
  • Country
  • IMMP Australia
  • SEG United States
  • Employees
  • IMMP N/A
  • SEG N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • SEG
  • Sector
  • IMMP Health Care
  • SEG
  • Exchange
  • IMMP Nasdaq
  • SEG NYSE
  • Market Cap
  • IMMP 304.0M
  • SEG 343.2M
  • IPO Year
  • IMMP N/A
  • SEG N/A
  • Fundamental
  • Price
  • IMMP $1.93
  • SEG $26.50
  • Analyst Decision
  • IMMP Buy
  • SEG
  • Analyst Count
  • IMMP 2
  • SEG 0
  • Target Price
  • IMMP $8.50
  • SEG N/A
  • AVG Volume (30 Days)
  • IMMP 98.7K
  • SEG 78.8K
  • Earning Date
  • IMMP 02-27-2025
  • SEG 02-05-2025
  • Dividend Yield
  • IMMP N/A
  • SEG N/A
  • EPS Growth
  • IMMP N/A
  • SEG N/A
  • EPS
  • IMMP N/A
  • SEG N/A
  • Revenue
  • IMMP $2,563,302.00
  • SEG $111,487,000.00
  • Revenue This Year
  • IMMP N/A
  • SEG N/A
  • Revenue Next Year
  • IMMP $47.79
  • SEG N/A
  • P/E Ratio
  • IMMP N/A
  • SEG N/A
  • Revenue Growth
  • IMMP 9.59
  • SEG 36.09
  • 52 Week Low
  • IMMP $1.66
  • SEG $22.51
  • 52 Week High
  • IMMP $3.34
  • SEG $36.50
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 42.28
  • SEG N/A
  • Support Level
  • IMMP $2.00
  • SEG N/A
  • Resistance Level
  • IMMP $2.05
  • SEG N/A
  • Average True Range (ATR)
  • IMMP 0.09
  • SEG 0.00
  • MACD
  • IMMP -0.02
  • SEG 0.00
  • Stochastic Oscillator
  • IMMP 8.33
  • SEG 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About SEG SEAPORT ENTERTAINMENT GROUP INC

Seaport Entertainment Group Inc own, operate and develop a unique collection of assets positioned at the intersection of entertainment and real estate. Its objective is to integrate one-of-a-kind real estate assets with a variety of restaurant, retail and leisure offerings to form vibrant mixed-use destinations where customers can work, play and socialize in one cohesive setting. The company has three operating segments: (1) Landlord Operations; (2) Hospitality; and (3) Sponsorships, Events, and Entertainment. Key revenue is generated from Landlord Operations which consists of the company's rental operations.

Share on Social Networks: